Intervacc announced that the first batch of Strangvac, a vaccine against equine Strangles, has been released for sale in Sweden.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.175 SEK | 0.00% | +4.24% | -34.04% |
03-04 | Intervacc AB Announces Changes in the Nomination Committee | CI |
02-28 | Intervacc's Acting CEO Assumes Role Permanently | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.04% | 28.84M | |
-2.90% | 103B | |
+1.57% | 95.28B | |
+1.46% | 22.15B | |
-16.14% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.28% | 16.05B | |
+5.54% | 13.68B | |
+33.14% | 12.17B |
- Stock Market
- Equities
- IVACC Stock
- News Intervacc AB
- Intervacc Announces Release of First Batch of Strangvac, a Vaccine against Equine Strangles